New Leaf Venture Partners lead $65 Mln Series A for Aptinyx
Aptinyx Inc has completed a $65 million Series A financing round led by New Leaf Venture Partners. New investors Frazier Healthcare Partners, Longitude Capital and Osage University participated in the round. Existing investors including Adams Street Partners, LVP Life Science Ventures, PathoCapital, Goudy Park Capital, Beecken Petty O'Keefe & Company and Northwestern University also took part. Evanston, Illinois-based Aptinyx is abiopharmaceutical company developing treatments of neurological disorders.
10 May 2016•3 mins read
